Double‐blind placebo‐controlled challenge showed that peanut oral immunotherapy was effective for severe allergy without negative effects on airway inflammation
- 10 January 2017
- journal article
- research article
- Published by Wiley in Acta Paediatrica
- Vol. 106 (2) , 274-281
Abstract
Aim: This study examined the efficacy and the safety of peanut oral immunotherapy (OIT).Methods: We recruited 60 patients aged six years to 18 years who had a moderate‐to‐severe reaction to a double‐blind placebo‐controlled peanut challenge: 39 received OIT during an eight‐month build‐up phase and maintenance phase and 21 controls avoided peanuts. We measured specific immunoglobulin E and G4 (IgE and IgG4) to peanuts and to Ara h 1, 2, 3, 8 and 9 and monitored adverse events, bronchial hyper‐responsiveness (BHR) to methacholine and fractional concentrations of exhaled nitric oxide (FeNO). The median follow‐up period was 30 months.Results: Most (85%) of the OIT patients passed the build‐up phase and 67% tolerated 5 g of peanuts during the post‐treatment challenge. No controls were desensitised, with a risk ratio of 29 and 95% confidence interval of 1.9–455. During OIT, IgE to peanut, Ara h 1, 2 and 3 decreased and IgG4 increased. Consuming peanuts had no harmful effects on BHR or FeNO. The annual incidence rate of emergency visits during the follow‐up period was 11% or 3.0 per 10 000 patient‐days.Conclusion: Peanut OIT was efficacious in severe allergies without negative effects on airway inflammation, but unpredictable long‐term reactions might occur.Keywords
Funding Information
- Päivikki ja Sakari Sohlbergin Säätiö
- Allergia- ja Astmaliitto
This publication has 24 references indexed in Scilit:
- Administration of a probiotic with peanut oral immunotherapy: A randomized trialJournal of Allergy and Clinical Immunology, 2015
- Assessing the efficacy of oral immunotherapy for the desensitisation of peanut allergy in children (STOP II): a phase 2 randomised controlled trialThe Lancet, 2014
- Food allergy: Epidemiology, pathogenesis, diagnosis, and treatmentJournal of Allergy and Clinical Immunology, 2014
- Sustained unresponsiveness to peanut in subjects who have completed peanut oral immunotherapyJournal of Allergy and Clinical Immunology, 2014
- Effect of oral immunotherapy to peanut on food-specific quality of lifeAnnals of Allergy, Asthma & Immunology, 2012
- Oral Immunotherapy for Treatment of Egg Allergy in ChildrenNew England Journal of Medicine, 2012
- Time trends in the prevalence of peanut allergy: three cohorts of children from the same geographical location in the UKAllergy, 2009
- Impact of peanut allergy on quality of life, stress and anxiety in the familyAllergy, 2009
- A randomized, double-blind, placebo-controlled study of milk oral immunotherapy for cow's milk allergyJournal of Allergy and Clinical Immunology, 2008
- Further fatalities caused by anaphylactic reactions to food, 2001-2006Journal of Allergy and Clinical Immunology, 2007